BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Interventional Spine, Inc. Announces Continued Success With Its Unique PERPOS(R) Percutaneous Cervical System


8/16/2010 8:42:21 AM

IRVINE, Calif., Aug. 16 /PRNewswire/ -- Interventional Spine, Inc. today announced the completion of another successful surgery with the unique PERPOS Percutaneous Cervical System for the treatment of neck pain.

(Logo: http://photos.prnewswire.com/prnh/20100419/LA88318LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100419/LA88318LOGO)

To the Company's knowledge, the PERPOS Percutaneous Cervical System is the only product that can stabilize the posterior cervical spine with a truly percutaneous procedure. Designed based on the experience gained with the use of its PERPOS lumbar system, in use in the United States since 2005, the company believes that its percutaneous approach to the cervical spine will minimize intra and post-operative patient morbidity, reduce procedure time and provide cost efficiencies to hospitals and surgeons alike.

The PERPOS Percutaneous Cervical System includes a 3.8mm CS Facet Compression Device which is indicated for the treatment of Spondylolisthesis, Spondylolysis, Degenerative Disc Disease (DDD), degeneration of the facets with instability and fracture, Pseudoarthrosis, and also for patients that have failed previous fusion of the cervical spine. Its intended use is to stabilize the spine as an aid to fusion through bilateral immobilization of the facet joints via bilateral facet fixation, with or without bone graft, at single or multiple levels from C2 to S1. Currently, there are approximately 125,000 cervical spine procedures completed each year in the United States and an equal number performed internationally. The Company estimates that the market for the PERPOS Percutaneous Cervical System is over $450 million annually on a worldwide basis.

The surgery was performed at the Mercy Medical Center in Redding, CA, by Dr. David Bradley Jones, MD. Upon completing the procedure, Dr. Jones commented: "For the true percutaneous approach, it is a huge benefit for the patient in post op recovery less pain and less risk of wound complications. From a hospital standpoint, the percutaneous application in a posterior cervical fusion case allows for a much reduced length of stay therefore higher contribution to margin compared to an open procedure. I was able to successfully accomplish my desired goal of allowing a decompression and fusion in this posterior cervical fusion (PCF) revision case."

Walter A. Cuevas, Chief Executive Officer of Interventional Spine commented: "The PERPOS Percutaneous Cervical System has some key patented attributes which make it unique among other posterior cervical systems in the market." The product was officially launched at the International Society for the Advancement of Spine Surgery meeting in New Orleans on April 27 30, 2010.

Interventional Spine, Inc. is a privately held company based in Irvine, California that designs, develops and markets patented implantable devices for the spine that can be deployed via percutaneous techniques. Supported by the Company's unique product introduction systems, Interventional Spine's products provide benefits to patients, surgeons and hospitals. More information on the Company and its products can be found at: www.i-spineinc.com.

FOR FURTHER INFORMATION CONTACT:

Walter Cuevas

Chief Executive Officer

949-472-0006



SOURCE Interventional Spine, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES